基于二元固体脂质基质的布洛芬负载固体脂质纳米颗粒增强稳定性和皮肤渗透性:表面活性剂和脂质成分的影响

IF 5.2 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Thitirat Chantaburanan, Veerawat Teeranachaideekul, Anchalee Jintapattanakit, Doungdaw Chantasart, Varaporn Buraphacheep Junyaprasert
{"title":"基于二元固体脂质基质的布洛芬负载固体脂质纳米颗粒增强稳定性和皮肤渗透性:表面活性剂和脂质成分的影响","authors":"Thitirat Chantaburanan,&nbsp;Veerawat Teeranachaideekul,&nbsp;Anchalee Jintapattanakit,&nbsp;Doungdaw Chantasart,&nbsp;Varaporn Buraphacheep Junyaprasert","doi":"10.1016/j.ijpx.2023.100205","DOIUrl":null,"url":null,"abstract":"<div><h3>Hypothesis</h3><p>The type of emulsifier selected has an impact on the physicochemical properties of solid lipid nanoparticles (SLNs). This study was designed to compare the effects of emulsifiers on the physicochemical properties and <em>in vitro</em> skin performance of SLNs prepared from a binary mixture of Softisan® 378 (S378) and cetyl palmitate (CP) to those of SLNs prepared from only CP and S378.</p></div><div><h3>Experiments</h3><p>SLNs were prepared from CP, S378, or a binary mixture of CP and S378 (1:1 <em>w</em>/w) as the lipid phase and stabilized with Tego®Care 450 (TG450) or poloxamer 188 (P188) containing 1.0% <em>w</em>/w ibuprofen loading. The physicochemical properties including the particle size, polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (E.E.), crystallinity (%CI), and polymorphism were determined after production and after storage for 180 days under different conditions. In addition, <em>in vitro</em> drug release and permeation through human skin was studied after production and storage at room temperature for 180 days.</p></div><div><h3>Finding</h3><p>The particle sizes of ibuprofen-loaded SLNs (IBSLNs) stabilized with P188 (IBSLN-P188) were smaller than those of SLNs stabilized with TG450 (IBSLN-TG450) (<em>p</em> &lt; 0.05). After 180 days, the particle sizes of the IBSLNs were slightly increased compared to those at the initial time but were &lt;250 nm. The IBSLN-TG450 sample showed a higher %CI than IBSLN-P188 prepared with similar propotions of CP and S378, and ibuprofen crystals were observed in the IBSLN1-TG450 sample after storage at 4 °C for 180 days. Based on the result of the <em>in vitro</em> release study and the <em>in vitro</em> skin permeation test, the addition of S378 into the CP-matrix modified ibuprofen release and skin permeation both permeated ibuprofen through the epidermis and retained ibuprofen in the epidermis. In addition, the storage time affected the release and skin permeation of ibuprofen from the SLNs, which depended on the composition of the IBSLNs.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100205"},"PeriodicalIF":5.2000,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/1d/main.PMC10440359.pdf","citationCount":"1","resultStr":"{\"title\":\"Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions\",\"authors\":\"Thitirat Chantaburanan,&nbsp;Veerawat Teeranachaideekul,&nbsp;Anchalee Jintapattanakit,&nbsp;Doungdaw Chantasart,&nbsp;Varaporn Buraphacheep Junyaprasert\",\"doi\":\"10.1016/j.ijpx.2023.100205\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Hypothesis</h3><p>The type of emulsifier selected has an impact on the physicochemical properties of solid lipid nanoparticles (SLNs). This study was designed to compare the effects of emulsifiers on the physicochemical properties and <em>in vitro</em> skin performance of SLNs prepared from a binary mixture of Softisan® 378 (S378) and cetyl palmitate (CP) to those of SLNs prepared from only CP and S378.</p></div><div><h3>Experiments</h3><p>SLNs were prepared from CP, S378, or a binary mixture of CP and S378 (1:1 <em>w</em>/w) as the lipid phase and stabilized with Tego®Care 450 (TG450) or poloxamer 188 (P188) containing 1.0% <em>w</em>/w ibuprofen loading. The physicochemical properties including the particle size, polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (E.E.), crystallinity (%CI), and polymorphism were determined after production and after storage for 180 days under different conditions. In addition, <em>in vitro</em> drug release and permeation through human skin was studied after production and storage at room temperature for 180 days.</p></div><div><h3>Finding</h3><p>The particle sizes of ibuprofen-loaded SLNs (IBSLNs) stabilized with P188 (IBSLN-P188) were smaller than those of SLNs stabilized with TG450 (IBSLN-TG450) (<em>p</em> &lt; 0.05). After 180 days, the particle sizes of the IBSLNs were slightly increased compared to those at the initial time but were &lt;250 nm. The IBSLN-TG450 sample showed a higher %CI than IBSLN-P188 prepared with similar propotions of CP and S378, and ibuprofen crystals were observed in the IBSLN1-TG450 sample after storage at 4 °C for 180 days. Based on the result of the <em>in vitro</em> release study and the <em>in vitro</em> skin permeation test, the addition of S378 into the CP-matrix modified ibuprofen release and skin permeation both permeated ibuprofen through the epidermis and retained ibuprofen in the epidermis. In addition, the storage time affected the release and skin permeation of ibuprofen from the SLNs, which depended on the composition of the IBSLNs.</p></div>\",\"PeriodicalId\":14280,\"journal\":{\"name\":\"International Journal of Pharmaceutics: X\",\"volume\":\"6 \",\"pages\":\"Article 100205\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2023-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/1d/main.PMC10440359.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics: X\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S259015672300049X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics: X","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S259015672300049X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

摘要

假设所选择的乳化剂类型对固体脂质纳米颗粒(SLNs)的物理化学性质有影响。本研究旨在比较乳化剂对由Softisan®378(S378)和棕榈酸十六烷基酯(CP)的二元混合物制备的SLN的物理化学性质和体外皮肤性能的影响,或CP和S378的二元混合物(1:1 w/w)作为脂相,并用含有1.0%w/w布洛芬负载量的Tego®Care 450(TG450)或泊洛沙姆188(P188)稳定。在不同条件下生产和储存180天后,测定了物理化学性质,包括粒度、多分散指数(PDI)、ζ电位(ZP)、包封效率(E.E.)、结晶度(%CI)和多态性。此外,在室温下生产和储存180天后,研究了药物通过人体皮肤的体外释放和渗透。结果用P188(IBSLN-P188)稳定的布洛芬负载的SLN(IBSLN)的粒径小于用TG450(IBSLN-TG450)稳定的SLN的粒径(p<0.05);250纳米。IBSLN-TG450样品显示出比用类似比例的CP和S378制备的IBSLN-P188更高的%CI,并且在4°C下储存180天后,在IBSLN1-TG450样品中观察到布洛芬晶体。基于体外释放研究和体外皮肤渗透测试的结果,在CP基质中添加S378改性布洛芬释放和皮肤渗透都使布洛芬穿过表皮并将布洛芬保留在表皮中。此外,储存时间影响布洛芬从IBSLN中的释放和皮肤渗透,这取决于IBSLN的组成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions

Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions

Hypothesis

The type of emulsifier selected has an impact on the physicochemical properties of solid lipid nanoparticles (SLNs). This study was designed to compare the effects of emulsifiers on the physicochemical properties and in vitro skin performance of SLNs prepared from a binary mixture of Softisan® 378 (S378) and cetyl palmitate (CP) to those of SLNs prepared from only CP and S378.

Experiments

SLNs were prepared from CP, S378, or a binary mixture of CP and S378 (1:1 w/w) as the lipid phase and stabilized with Tego®Care 450 (TG450) or poloxamer 188 (P188) containing 1.0% w/w ibuprofen loading. The physicochemical properties including the particle size, polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (E.E.), crystallinity (%CI), and polymorphism were determined after production and after storage for 180 days under different conditions. In addition, in vitro drug release and permeation through human skin was studied after production and storage at room temperature for 180 days.

Finding

The particle sizes of ibuprofen-loaded SLNs (IBSLNs) stabilized with P188 (IBSLN-P188) were smaller than those of SLNs stabilized with TG450 (IBSLN-TG450) (p < 0.05). After 180 days, the particle sizes of the IBSLNs were slightly increased compared to those at the initial time but were <250 nm. The IBSLN-TG450 sample showed a higher %CI than IBSLN-P188 prepared with similar propotions of CP and S378, and ibuprofen crystals were observed in the IBSLN1-TG450 sample after storage at 4 °C for 180 days. Based on the result of the in vitro release study and the in vitro skin permeation test, the addition of S378 into the CP-matrix modified ibuprofen release and skin permeation both permeated ibuprofen through the epidermis and retained ibuprofen in the epidermis. In addition, the storage time affected the release and skin permeation of ibuprofen from the SLNs, which depended on the composition of the IBSLNs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
6.60
自引率
0.00%
发文量
32
审稿时长
24 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信